CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Angiobiomed's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 27, 2021Adrenomedullin Binder For Use In Therapy Of Cancer1

Top competitors of Angiobiomed

Top competitors of Angiobiomed based on patent oppositions.